Tolrestat


Concise Prescribing Info
Action
Description: Tolrestat inhibits the enzyme aldose reductase which catalyses the conversion of glucose to sorbitol. It was investigated in the management of diabetic complications.
MIMS Class
Disclaimer: This information is independently developed by MIMS based on Tolrestat from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2020 MIMS. All rights reserved. Powered by MIMS.com
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in